Halozyme Therapeutics Inc. (NASDAQ:HALO) shares fell to a low of $41.29 before closing at $41.41. Intraday shares traded counted 2.82 million, which was -171.28% lower
Halozyme Therapeutics Inc. (NASDAQ:HALO) shares fell to a low of $42.085 before closing at $42.95. Intraday shares traded counted 0.82 million, which was 20.87% higher
Halozyme Therapeutics Inc. (NASDAQ:HALO) shares fell to a low of $38.95 before closing at $39.46. Intraday shares traded counted 0.9 million, which was 15.53% higher
Halozyme Therapeutics Inc. (NASDAQ:HALO) shares traded lower over the last trading session, losing -0.92% on 06/03/21. The shares fell to a low of $38.65 before
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
© 2024, Fueled by Smart TechOne
